Denali Therapeutics Inc (DNLI)
22.10
+3.31%
Denali Therapeutics Inc (DNLI) is currently trading at $22.10. This represents a gain of 3.31% from the previous session. With a market capitalization of $3.45B, DNLI is a key component of the Health Care sector. Investors looking to trade DNLI should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade DNLI commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Denali Therapeutics Inc (DNLI) shows a bullish trend. Analysts are watching the 22.59 level closely.
Fundamentals
Mkt Cap3.45B
P/E Ratio0.0000
Volume890,235
60-Day Technical Chart
Advanced Charting
Need more indicators for DNLI? Use the world's #1 platform.
Open DNLI on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $22
| Metric |
DNLI +3.31% |
BMNR +12.50% |
HL +0.97% |
USAR +0.15% |
|---|---|---|---|---|
| Price | $22.10 | $21.87 | $23.87 | $20.40 |
| Mkt Cap | $3.45B | $9.95B | $16.00B | $4.45B |
| - | View → | View → | View → |
Latest Headlines
Denali Therapeutics Inc. (DNLI) Stock Analysis: Strong Buy Ratings Signal a 57% Potential Upside
DirectorsTalk Interviews • Feb 24, 2026
$DNLI stock is down 11% today. Here's what we see in our data.
Quiver Quantitative • Dec 10, 2025
Denali Therapeutics (NASDAQ: DNLI) prices $200M equity deal at $17.50
Stock Titan • Dec 10, 2025
Denali Therapeutics stock falls after announcing $200 million public offering
Investing.com • Dec 9, 2025
Denali Therapeutics (DNLI) Weighs FDA Priority Review And Rival Setback: What Does It Mean Long Term?
simplywall.st • Feb 2, 2026
● Gemini Agentic AI Analyst Insight for DNLI
Market Education
- Making Sense of Money: How Interest Rates, Bonds, and Stocks Affect Your Wallet Feb 21, 2024
- The Basics of the Stock Market for Beginners Aug 25, 2023
- Institutions vs Retail Traders - Showdown, Apes are winning May 24, 2021
External Research